Bridging Academics and Pharma Industry

NASH Roundtable members are accessible to biopharma to consult on NASH development programs, including:

  • Clinical development and regulatory planning
  • Clinical and pre-clinical study design
  • Biomarker strategies
  • Applicable and relevant clinical research methods
  • Asset evaluation and risk assessment
  • Competitive and scientific landscape review

The NASH Roundtable also hosts forums twice a year to coincide with the EASL and AALSD Liver Conferences. As of 2021, a select group of biopharma guests is also invited to attend the forums. For more information or to inquire about attending a NASH Roundtable event, please contact